上海亦立医药有限公司成立，注册资本500万人民币

Core Viewpoint - Shanghai Yili Pharmaceutical Co., Ltd. has been established with a registered capital of 5 million RMB, fully owned by Hangzhou Yili Pharmaceutical Co., Ltd. [1] Company Summary - The legal representative of Shanghai Yili Pharmaceutical Co., Ltd. is Yu Feng [1] - The company is registered under the scientific research and technical service industry, specifically in research and experimental development [1] - The business scope includes medical research and experimental development (excluding human stem cells, gene diagnosis, and treatment technology development and application), software development, and various technical services [1] Shareholding Structure - Hangzhou Yili Pharmaceutical Co., Ltd. holds 100% of the shares in Shanghai Yili Pharmaceutical Co., Ltd. [1] Operational Details - The company is located in the China (Shanghai) Pilot Free Trade Zone, specifically at 211 Fute North Road, Room 368 [1] - The business registration is valid until December 17, 2025, with no fixed term thereafter [1] - The company is classified as an other limited liability company [1]